Satellite Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $82.5M

  • Investors
  • 8

Satellite Bio General Information

Description

Developer of a therapeutic platform designed to create cell therapies to eradicate diseases. The company's platform offers implantable satellite organs as living therapeutic systems that can help with diseases caused by the interaction of genetic and environmental factors, enabling medical professionals to replace critical organ functions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 73D Chapel Street
  • Newton, MA 02458
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 73D Chapel Street
  • Newton, MA 02458
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Satellite Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 25-Feb-2022 $82.5M Completed Generating Revenue
3. Seed Round 17-Nov-2020 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2019 Completed Startup
To view Satellite Bio’s complete valuation and funding history, request access »

Satellite Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Satellite Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Satellite Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutic platform designed to create cell therapies to eradicate diseases. The company's platform offe
Biotechnology
Newton, MA
21 As of 2026

Greensboro, NC
 

Tucson, AZ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Satellite Bio Competitors (2)

One of Satellite Bio’s 2 competitors is Precise Bio, a Venture Capital-Backed company based in Greensboro, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Precise Bio Venture Capital-Backed Greensboro, NC
Avery Therapeutics Venture Capital-Backed Tucson, AZ
You’re viewing 2 of 2 competitors. Get the full list »

Satellite Bio Patents

Satellite Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026136912-A2 Culture media and conditions for in vitro expansion and/or maturation of hepatocytes Pending 19-Dec-2024
WO-2026136912-A3 Culture media and conditions for in vitro expansion and/or maturation of hepatocytes Pending 19-Dec-2024
US-20260176589-A1 Culture media and conditions for in vitro expansion of hepatocytes Pending 19-Dec-2024
WO-2026136915-A1 In vitro partial reprogramming of hepatocytes Pending 19-Dec-2024
WO-2025230947-A1 Engineered hepatocytes for secreting polypeptides Pending 30-Apr-2024 C07K14/605
To view Satellite Bio’s complete patent history, request access »

Satellite Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Satellite Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
Catalio Capital Management Venture Capital Minority
S32 Venture Capital Minority
aMoon Fund Venture Capital Minority
Lightspeed Venture Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Satellite Bio FAQs

  • When was Satellite Bio founded?

    Satellite Bio was founded in 2019.

  • Where is Satellite Bio headquartered?

    Satellite Bio is headquartered in Newton, MA.

  • What is the size of Satellite Bio?

    Satellite Bio has 21 total employees.

  • What industry is Satellite Bio in?

    Satellite Bio’s primary industry is Biotechnology.

  • Is Satellite Bio a private or public company?

    Satellite Bio is a Private company.

  • What is the current valuation of Satellite Bio?

    The current valuation of Satellite Bio is .

  • What is Satellite Bio’s current revenue?

    The current revenue for Satellite Bio is .

  • How much funding has Satellite Bio raised over time?

    Satellite Bio has raised $101M.

  • Who are Satellite Bio’s investors?

    Alumni Ventures, Catalio Capital Management, S32, aMoon Fund, and Lightspeed Venture Partners are 5 of 8 investors who have invested in Satellite Bio.

  • Who are Satellite Bio’s competitors?

    Precise Bio and Avery Therapeutics are competitors of Satellite Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process